Biomarin pharmaceutical market cap

WebApr 12, 2024 · The stock has a market capitalization of $18.25 billion, a PE ratio of 132.22 and a beta of 0.38. BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last announced its quarterly earnings... WebApr 10, 2024 · See the latest Biomarin Pharmaceutical Inc stock price (NASDAQ:BMRN), related news, valuation, dividends and more to help you make your investing decisions. …

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by …

WebJan 22, 2024 · Market Cap. $19B. Today's Change (-1.56%) -$1.55. Current Price ... That's why I like BioMarin Pharmaceutical (BMRN-1.56%), a biotech company founded in … WebMarket Cap: $17.4B: Shares Short: 7M: Financials See more. Revenue (12 Mos) $2B: Revenue Growth (YoY) 19.5%: ... BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials. ... 770 Lindaro Street, San Rafael, CA, United States, 94901: Sector: Healthcare: Industry: Biotechnology: Full-Time Employees ... highlights north thailand tour https://borensteinweb.com

BioMarin Pharmaceutical BMRN Stock Price, Company Overview …

WebApr 11, 2024 · With Biomarin Pharmaceutical stock trading at $94.30 per share, the total value of Biomarin Pharmaceutical stock (market capitalization) is $17.59B. Biomarin … WebCurrent and historical revenue charts for BioMarin Pharmaceutical. As of April 2024 BioMarin Pharmaceutical's TTM revenue is of $2.09 B. companies: 7,323 total market … WebFind the latest BioMarin Pharmaceutical Inc. (BMRN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 18.394B: Beta (5Y ... Discover historical prices for BMRN stock on Yahoo Finance. View daily, weekly or … Find the latest BioMarin Pharmaceutical Inc. (BMRN) stock discussion in Yahoo … Interactive Chart for BioMarin Pharmaceutical Inc. (BMRN), analyze all … View the basic BMRN option chain and compare options of BioMarin … See BioMarin Pharmaceutical Inc. (BMRN) stock analyst estimates, including … See the company profile for BioMarin Pharmaceutical Inc. (BMRN) including … Find out the direct holders, institutional holders and mutual fund holders for … Find out all the key statistics for BioMarin Pharmaceutical Inc. (BMRN), including … See BioMarin Pharmaceutical Inc. (BMRN) Environment, Social and Governance … Get the detailed quarterly/annual income statement for BioMarin Pharmaceutical … highlights norderney

Crossmark Global Holdings Inc. Takes $209,000 Position in BioMarin ...

Category:Crossmark Global Holdings Inc. Takes $209,000 Position in BioMarin ...

Tags:Biomarin pharmaceutical market cap

Biomarin pharmaceutical market cap

BMRN - Biomarin Pharmaceutical Inc Stock Price Quote - NASDAQ Mo…

WebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? … Web24 rows · As of March 2024 BioMarin Pharmaceutical has a market cap of $16.71 Billion. This makes BioMarin Pharmaceutical the world's 978th most valuable company by market cap according to our data. The …

Biomarin pharmaceutical market cap

Did you know?

WebApr 10, 2024 · BMRN Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. … Web26 rows · Mar 22, 2024 · Biomarin Pharmaceutical Market Cap: 17.44B for March 29, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to …

WebApr 6, 2024 · About the company. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and … WebDec 30, 2024 · Pharma giant Pfizer recently announced that it will acquire Arena Pharmaceuticals for $100 per share or a total equity value of approximately $6.7 billion to further expand its portfolio. Per...

WebGet the latest Biomarin Pharmaceutical Inc (BMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebBioMarin Pharmaceutical Symbol: BMRNRank: #820Price: $111.81(-0.9128%) Market Cap: $20.7B($-189.6M)Industry: BiotechnologySector: HealthcareCountry: United StatesInsiders: 0.552%Institutions: 101.394% BioMarin Pharmaceutical Inc. Technicals 52 Week High: $114.8 52 Week Low: $70.73 50 Day MA: $99.43 200 Day MA: $88.59

WebBiomarin Pharmaceutical Inc (BMRN) Stock Price & News - Google Finance Home BMRN • NASDAQ Biomarin Pharmaceutical Inc Follow Share $96.60 After Hours: $96.60 (0.00%) 0.00 Closed: Apr 3,...

WebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … highlights northridge caWebApr 3, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The company has a market cap of $18.07 billion, a price-to-earnings ratio of 131.41 and a beta of 0.39. highlights norwich v millwallWebMar 22, 2024 · BioMarin Pharmaceutical Inc. (BMRN) NASDAQ: BMRN · IEX Real-Time Price · USD. Add to Watchlist 90.08-2.00 (-2.17%) ... Profile; Chart; BMRN Market Cap. … highlights not saving in excelWebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock has a 50 day simple moving average of $100.53 and a 200-day simple moving average of $98.13. highlights norwich v lutonWebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of $70.73 and a twelve month high... highlights norwich v bristol cityWebApr 13, 2024 · The business’s fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The firm has a market capitalization of $18.27 billion, a … highlights not printing in adobeWebBioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Monday, February 27, at 4:30 p.m. ET. January 8, 2024. BioMarin Announces Stable and Durable Annualized … highlights norwich v hull